ER, PR, HER2, and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trialAnn S. Knoop,Anne-Vibeke Laenkholm,Maj-Britt Jensen,Kirsten V. Nielsen, Jorn Andersen,Dorte Nielsen,Bent EjlertsenAPMIS(2014)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要